Biomarker Analyses in CLEOPATRA: A phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer

  1. Baselga, J.
  2. Cortés, J.
  3. Im, S.-A.
  4. Clark, E.
  5. Ross, G.
  6. Kiermaier, A.
  7. Swain, S.M.
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Argitalpen urtea: 2014

Alea: 32

Zenbakia: 33

Orrialdeak: 3753-3761

Mota: Artikulua

DOI: 10.1200/JCO.2013.54.5384 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus